Bruce Jackson
Stock Analyst at Benchmark
(0.96)
# 3,613
Out of 4,829 analysts
125
Total ratings
27.27%
Success rate
-24.67%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLNN Clene | Maintains: Buy | $84 → $33 | $2.63 | +1,154.75% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.96 | +677.03% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $61.10 | +30.93% | 9 | Mar 26, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $5.5 → $4.5 | $0.32 | +1,328.57% | 5 | Mar 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | n/a | $1.19 | - | 14 | Feb 27, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $8.05 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $51.63 | +25.90% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.50 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.55 | +445.45% | 8 | Nov 22, 2024 | |
| MLSS Milestone Scientific | Reiterates: Speculative Buy | $1.25 | $0.95 | +31.58% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.69 | +907.34% | 7 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.95 | +214.93% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.21 | +126.24% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.80 | +3,673.58% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $2 | $0.19 | +980.50% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.82 | +1,973.93% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.13 | +2,023.89% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $0.46 | +119.78% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.87 | +74.22% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.00 | +400.00% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.87 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.42 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.43 | +23,233.14% | 1 | Aug 8, 2022 |
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $2.63
Upside: +1,154.75%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.96
Upside: +677.03%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $61.10
Upside: +30.93%
Harvard Bioscience
Mar 24, 2025
Maintains: Speculative Buy
Price Target: $5.5 → $4.5
Current: $0.32
Upside: +1,328.57%
Humacyte
Feb 27, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.19
Upside: -
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.05
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $51.63
Upside: +25.90%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.50
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.55
Upside: +445.45%
Milestone Scientific
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.95
Upside: +31.58%
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.69
Upside: +907.34%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.95
Upside: +214.93%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.21
Upside: +126.24%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.80
Upside: +3,673.58%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.19
Upside: +980.50%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.82
Upside: +1,973.93%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.13
Upside: +2,023.89%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.46
Upside: +119.78%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.87
Upside: +74.22%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.00
Upside: +400.00%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.87
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $19.42
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.43
Upside: +23,233.14%